Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 23987180)

1.

Urinary proteome analysis in patients with stable SFU grade 4 ureteropelvic junction obstruction differs from normal.

Mesrobian HG, Kryger JV, Groth TW, Fiscus GE, Mirza SP.

Urology. 2013 Sep;82(3):745.e1-10. doi: 10.1016/j.urology.2013.06.009.

PMID:
23987180
2.

Candidate urinary biomarker discovery in ureteropelvic junction obstruction: a proteomic approach.

Mesrobian HG, Mitchell ME, See WA, Halligan BD, Carlson BE, Greene AS, Wakim BT.

J Urol. 2010 Aug;184(2):709-14. doi: 10.1016/j.juro.2010.03.061.

PMID:
20639044
3.

Urinary biomarkers in hydronephrosis.

Madsen MG.

Dan Med J. 2013 Feb;60(2):B4582. Review.

PMID:
23461995
4.

Urinary proteome analysis and the management of ureteropelvic junction obstruction.

Mesrobian HG.

Pediatr Nephrol. 2010 Sep;25(9):1595-6. doi: 10.1007/s00467-010-1521-2. Epub 2010 Apr 21.

PMID:
20407913
5.

Prediction of the outcome of antenatal hydronephrosis: significance of urinary EGF.

Li Z, Zhao Z, Liu X, Su Z, Shang X, Wen J.

Pediatr Nephrol. 2012 Dec;27(12):2251-9. doi: 10.1007/s00467-012-2243-4. Epub 2012 Jul 8.

PMID:
22773267
6.

Urinary proteome analysis identifies infants but not older children requiring pyeloplasty.

Drube J, Zürbig P, Schiffer E, Lau E, Ure B, Glüer S, Kirschstein M, Pape L, Decramer S, Bascands JL, Schanstra JP, Mischak H, Ehrich JH.

Pediatr Nephrol. 2010 Sep;25(9):1673-8. doi: 10.1007/s00467-010-1455-8. Epub 2010 Feb 24.

PMID:
20180135
7.

Results of a practical protocol for management of prenatally detected hydronephrosis due to ureteropelvic junction obstruction.

Karnak I, Woo LL, Shah SN, Sirajuddin A, Ross JH.

Pediatr Surg Int. 2009 Jan;25(1):61-7. doi: 10.1007/s00383-008-2294-6. Epub 2008 Nov 29.

PMID:
19043723
8.

Urinary proteome analysis at 5-year followup of patients with nonoperated ureteropelvic junction obstruction suggests ongoing kidney remodeling.

Bandin F, Siwy J, Breuil B, Mischak H, Bascands JL, Decramer S, Schanstra JP.

J Urol. 2012 Mar;187(3):1006-11. doi: 10.1016/j.juro.2011.10.169. Epub 2012 Jan 20.

PMID:
22264461
9.

The value of newborn urinary proteome analysis in the evaluation and management of ureteropelvic junction obstruction: a cost-effectiveness study.

Mesrobian HG.

World J Urol. 2009 Jun;27(3):379-83. doi: 10.1007/s00345-008-0355-z. Epub 2008 Nov 26.

PMID:
19034461
10.

Urine levels of transforming growth factor-beta 1 in children with ureteropelvic junction obstruction.

Palmer LS, Maizels M, Kaplan WE, Firlit CF, Cheng EY.

Urology. 1997 Nov;50(5):769-73.

PMID:
9372890
11.

Urinary cytokine profiles in unilateral congenital hydronephrosis.

Taranta-Janusz K, Wasilewska A, Dębek W, Waszkiewicz-Stojda M.

Pediatr Nephrol. 2012 Nov;27(11):2107-13. doi: 10.1007/s00467-012-2230-9. Epub 2012 Jun 29.

13.

Urinary NGAL, cystatin C, β2-microglobulin, and osteopontin significance in hydronephrotic children.

Madsen MG, Nørregaard R, Palmfeldt J, Olsen LH, Frøkiær J, Jørgensen TM.

Pediatr Nephrol. 2012 Nov;27(11):2099-106. doi: 10.1007/s00467-012-2217-6. Epub 2012 Jun 19.

PMID:
22710694
14.

Society for fetal urology recommendations for postnatal evaluation of prenatal hydronephrosis--will fewer voiding cystourethrograms lead to more urinary tract infections?

St Aubin M, Willihnganz-Lawson K, Varda BK, Fine M, Adejoro O, Prosen T, Lewis JM, Shukla AR.

J Urol. 2013 Oct;190(4 Suppl):1456-61. doi: 10.1016/j.juro.2013.03.038. Epub 2013 Jun 21.

PMID:
23791909
15.

Epidermal growth factor and monocyte chemotactic peptide-1: potential biomarkers of urinary tract obstruction in children with hydronephrosis.

Madsen MG, Nørregaard R, Palmfeldt J, Olsen LH, Frøkiær J, Jørgensen TM.

J Pediatr Urol. 2013 Dec;9(6 Pt A):838-45. doi: 10.1016/j.jpurol.2012.11.011. Epub 2012 Dec 8.

PMID:
23228281
16.

Factors indicating renal injury in pediatric bilateral ureteropelvic-junction obstruction.

Lee YS, Jeong HJ, Im YJ, Kim MJ, Lee MJ, Yun M, Han SW.

Urology. 2013 Apr;81(4):873-8. doi: 10.1016/j.urology.2012.09.064. Epub 2013 Feb 7.

PMID:
23395124
17.

Urinary angiotensinogen as a novel marker of obstructive nephropathy in children.

Taranta-Janusz K, Wasilewska A, Dębek W, Fiłonowicz R, Michaluk-Skutnik J.

Acta Paediatr. 2013 Sep;102(9):e429-33. doi: 10.1111/apa.12324. Epub 2013 Jul 10.

PMID:
23772991
18.

Diagnostic accuracy of renal pelvic dilatation for detecting surgically managed ureteropelvic junction obstruction.

Dias CS, Silva JM, Pereira AK, Marino VS, Silva LA, Coelho AM, Costa FP, Quirino IG, Simões E Silva AC, Oliveira EA.

J Urol. 2013 Aug;190(2):661-6. doi: 10.1016/j.juro.2013.02.014. Epub 2013 Feb 14.

PMID:
23416643
19.

Conservative treatment of ureteropelvic junction obstruction in children with antenatal diagnosis of hydronephrosis: lessons learned after 16 years of follow-up.

Chertin B, Pollack A, Koulikov D, Rabinowitz R, Hain D, Hadas-Halpren I, Farkas A.

Eur Urol. 2006 Apr;49(4):734-8. Epub 2006 Feb 17.

PMID:
16504374
20.

Renal biopsy in congenital ureteropelvic junction obstruction: evidence for parenchymal maldevelopment.

Huang WY, Peters CA, Zurakowski D, Borer JG, Diamond DA, Bauer SB, McLellan DL, Rosen S.

Kidney Int. 2006 Jan;69(1):137-43.

PMID:
16374434
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk